Zacks Investment Research downgraded shares of National Health Investors (NYSE:NHI) from a hold rating to a sell rating in a report released on Saturday morning, reports.

According to Zacks, “National Health Investors, Inc. is a real estate investment trust which invests in income producing health care properties primarily in the long-term care industry. The company provides current income for distribution to stockholders through investments in health care related facilities, including long-term care facilities, acute care hospitals, medical office buildings, retirement centers and assisted living facilities. “

Shares of National Health Investors stock opened at $81.77 on Friday. The firm’s fifty day simple moving average is $81.61 and its 200-day simple moving average is $79.09. National Health Investors has a 12 month low of $70.54 and a 12 month high of $84.75. The stock has a market capitalization of $3.58 billion, a price-to-earnings ratio of 14.92, a PEG ratio of 3.81 and a beta of 0.33. The company has a debt-to-equity ratio of 1.04, a current ratio of 14.42 and a quick ratio of 14.42.

National Health Investors (NYSE:NHI) last issued its quarterly earnings results on Thursday, August 8th. The real estate investment trust reported $0.92 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.37 by ($0.45). National Health Investors had a return on equity of 11.00% and a net margin of 50.71%. The business had revenue of $78.10 million for the quarter, compared to analyst estimates of $77.64 million. During the same quarter in the prior year, the company earned $1.38 EPS. The firm’s revenue for the quarter was up 7.0% on a year-over-year basis. Analysts anticipate that National Health Investors will post 5.49 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 8th. Stockholders of record on Monday, September 30th will be issued a $1.05 dividend. The ex-dividend date is Friday, September 27th. This represents a $4.20 dividend on an annualized basis and a dividend yield of 5.14%. National Health Investors’s payout ratio is 76.64%.

In related news, CIO Kevin Carlton Pascoe sold 900 shares of the firm’s stock in a transaction dated Tuesday, August 13th. The stock was sold at an average price of $82.46, for a total transaction of $74,214.00. Following the transaction, the executive now owns 27,826 shares of the company’s stock, valued at $2,294,531.96. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 5.11% of the stock is currently owned by corporate insiders.

Hedge funds have recently modified their holdings of the stock. Marshall Wace North America L.P. acquired a new stake in National Health Investors during the 1st quarter worth approximately $31,000. Farmers National Bank acquired a new position in shares of National Health Investors in the first quarter valued at approximately $49,000. Krane Funds Advisors LLC purchased a new stake in shares of National Health Investors during the second quarter worth approximately $58,000. Quadrant Capital Group LLC raised its stake in shares of National Health Investors by 306.7% during the first quarter. Quadrant Capital Group LLC now owns 793 shares of the real estate investment trust’s stock worth $61,000 after purchasing an additional 598 shares during the last quarter. Finally, Doyle Wealth Management purchased a new stake in shares of National Health Investors during the second quarter worth approximately $78,000. Hedge funds and other institutional investors own 69.71% of the company’s stock.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.

Featured Story: What is the Fibonacci sequence?

Get a free copy of the Zacks research report on National Health Investors (NHI)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with's FREE daily email newsletter.